Colgate-Palmolive
CL
Market cap $72.6B

89.58 USD

-1.04

1.15%

At close Jul 11, 4:00 PM EDT

After hours

89.70

+0.12

0.13%

1 day

-1.15%

5 days

-3.39%

1 month

-2.75%

3 months

-4.70%

6 months

2.85%

Year to date

-1.07%

1 year

-8.37%

5 years

21.94%

10 years

32.83%

About: Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

Employees: 34,000

Consumer Staples Household & Personal Products

0

Funds holding %

of 7,312 funds

0

Analysts bullish %

of 3 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 115

20% more funds holding in top 10

Funds holding in top 10: 10 [Q4 2024] → 12 (+2) [Q1 2025]

1% more capital invested

Capital invested by funds: $62.2B [Q4 2024] → $62.6B (+$468M) [Q1 2025]

0% less funds holding

Funds holding: 1,896 [Q4 2024] → 1,891 (-5) [Q1 2025]

0.34% less ownership

Funds ownership: 82.78% [Q4 2024] → 82.44% (-0.34%) [Q1 2025]

16% less repeat investments, than reductions

Existing positions increased: 640 | Existing positions reduced: 759

21% less call options, than puts

Call options by funds: $294M | Put options by funds: $374M

See Fund Rankings

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$103

15%

upside

Avg. target

$107

19%

upside

High target

$109

22%

upside

3 analyst ratings

3 positive

100%

0 neutral

0%

0 negative

0%

Citigroup Filippo Falorni	21%upside $108	Buy Maintained	28 Apr 2025
JP Morgan Andrea Teixeira	15%upside $103	Overweight Maintained	28 Apr 2025
UBS Peter Grom	22%upside $109	Buy Maintained	17 Apr 2025

See Analyst Rankings

Financial journalist opinion

Based on 9 articles about CL published over the past 30 days

Zacks Investment Research

4 Low-Beta Defensive Stocks to Buy as Rate Cut Uncertainty Continues

CL, KO, ATO, and FTS stand out as low-beta, high-dividend plays amid Fed rate cut delays and rising market volatility.

4 Low-Beta Defensive Stocks to Buy as Rate Cut Uncertainty Continues

Zacks Investment Research

Can Colgate's Pricing Strength Keep Earnings Buoyant in 2025?

CL's strategic pricing, margin gains and productivity moves support steady EPS growth into 2025 despite cost pressures.

Can Colgate's Pricing Strength Keep Earnings Buoyant in 2025?

Best Dividend Aristocrats For July 2025

Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising payouts in 2025 and an average growth rate of 4.86%. I identified 21 Aristocrats as both potentially undervalued and offering a projected long-term annualized return of at least 10%.

Best Dividend Aristocrats For July 2025

My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys

Markets remained volatile in May 2025 amid ongoing trade tensions and mixed signals from Washington and Wall Street. While U.S.-China talks quietly resumed, tariffs persisted and business sentiment stayed cautious, contributing to investor uncertainty. May's investments added $111 in annual dividends, keeping me on track with my goal of $100+ monthly income growth and a 7.4% yield on cost.

My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys

Zacks Investment Research

Colgate Taps Productivity Plan, Enhances Profits, Protects Margins

CL streamlines supply chain, modernizes manufacturing and cuts overhead to boost efficiency and execution.

Colgate Taps Productivity Plan, Enhances Profits, Protects Margins

Zacks Investment Research

4 Resilient Consumer Product Stocks to Monitor in a Challenging Market

CL, CLX, BJ and GO remain resilient as they navigate rising costs and shifting consumer trends with strategic moves.

4 Resilient Consumer Product Stocks to Monitor in a Challenging Market

5 Ideal 'Safer' Dividend Buys From Bloomberg's June Watch List

I highlight 15 dividend-paying stocks from Bloomberg's 50 Companies to Watch that meet my 'safer' criteria: free cash flow yields exceed dividend yields. The top ten dividend focus stocks offer an estimated average net gain of 15.48% by June 2026, with diversified sector representation and generally lower volatility. Five stocks - China Hongqiao, ITV, Vodacom, Subsea 7, and Advanced Info - stand out as 'ideal' for income investors, combining safety and attractive yield-to-price ratios.

5 Ideal 'Safer' Dividend Buys From Bloomberg's June Watch List

Colgate Declares Regular Quarterly Dividend

NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on August 15, 2025, to shareholders of record on July 18, 2025. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Hom.

Colgate Declares Regular Quarterly Dividend

Colgate-Palmolive: The Defensive Growth Case Is Delivering

Colgate-Palmolive is now fairly valued at 24x forward PE, offering a solid entry point for long-term investors seeking stability and steady growth. The company maintains dominant global market share in core segments and is expanding in pet nutrition, positioning it well for post-industry-bottom recovery. Recent results show resilient organic growth despite macro headwinds, with management expecting stabilization and a return to growth by year-end.

Colgate-Palmolive: The Defensive Growth Case Is Delivering

Zacks Investment Research

Momentum in Pet Business: A Catalyst for CL's Growth Phase?

Colgate sharpens its competitive edge in pet care, aiming to seize more market share.

Momentum in Pet Business: A Catalyst for CL's Growth Phase?

See News Rankings

Charts implemented using Lightweight Charts™